LipoScience seeks FDA clearance for cardiovascular testing device

02/1/2010 | American City Business Journals

LipoScience has filed an application with the FDA seeking clearance for Vantera, a device that would enable research laboratories to conduct on-site testing of blood samples for risks of heart diseases. CEO Rick Brajer said he is hopeful the company can secure FDA clearance later this year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA